J7173 Injection. concizumab-mtci, 0.5 milligrams
J-Codes
Also known as: concizumab, TFPI inhibitor, monoclonal antibody
Injection of concizumab-mtci, a monoclonal antibody against tissue factor pathway inhibitor, supplied as 0.5 milligrams per dose for hemophilia management.
Clinical Context
Indicated for prophylaxis of breakthrough bleeding in hemophilia A or B patients with inhibitors, enhances coagulation through TFPI pathway inhibition.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.